Key result
High-dose vitamin D reduces augmentation index by ~12% without altering 24-hour ambulatory blood pressure.
Why the study?
Vitamin D deficiency is associated with hypertension and cardiovascular disease, but mechanisms underlying vitamin D deficiency-mediated increased CVD risk remain unknown.
RCT (n=41)
Double-blind
Randomized
No
p-value: p=0.047
INTRODUCTION: Vitamin D deficiency is associated with the onset and progression of hypertension and cardiovascular disease (CVD). However, mechanisms underlying vitamin D deficiency-mediated increased risk of CVD remain unknown. We sought to examine the differential effect of high-dose versus low-dose vitamin D supplementation on markers of arterial stiffness among ~40 vitamin D deficient adults with prehypertension. METHODS: Participants were randomized to high-dose (4000 IU/d) versus low-dose (400 IU/d) oral vitamin D3 for 6 months. 24 hr ambulatory blood pressure (BP), carotid-femoral pulse wave velocity, and pulse wave analyses were obtained at baseline and after 6 months of vitamin D supplementation. RESULTS: There were no changes in resting BP or pulse wave velocity over 6 mo regardless of vitamin D dose (all p > 0.202). High-dose vitamin D decreased augmentation index and pressure by 12.3 ± 5.3% (p = 0.047) and 4.0 ± 1.5 mmHg (p = 0.02), respectively. However, these decreases in arterial stiffness were not associated with increases in serum 25-hydroxyvitamin D over 6 mo (p = 0.425). CONCLUSION: High-dose vitamin D supplementation appears to lower surrogate measures of arterial stiffness but not indices of central pulse wave velocity. Clinical Trial Registration. This trial is registered with www.clinicaltrials.gov (Unique Identifier: NCT01240512).
No takes yet. Share an insight, caveat, or question.
Zaleski et al. (2015) conducted an RCT in Prehypertension and Vitamin D Deficiency (n=41). High-dose oral vitamin D3 vs. Low-dose oral vitamin D3 (400 IU/d) was evaluated on Change in augmentation index (AIx) over 6 months (p=0.047). High-dose vitamin D supplementation decreased augmentation index by 12.3% and augmentation pressure by 4.0 mmHg over 6 months, but did not significantly alter 24-hour ambulatory blood pressure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: